Davies Collison Cave

The start-up behind Hungry Jack's plant-based 'Rebel Whopper' wants a court to review IP Australia's decision that a proposed patent covering its fake meat product didn't pass muster.

V2food, the CSIRO-backed start-up behind Hungry Jack's plant-based 'Rebel Whopper', has lost its bid to patent a product that changes colour when cooked in order to imitate the “meat experience”.

German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled. 

The CSIRO has successfully appealed a decision that blocked the government agency’s application to patent a method of producing high-fibre wheat.

Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno's generic version of schizophrenia drug Invega Sustenna.

Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea. 

After losing a fight over access to millions of seized documents, Fortescue has settled its trade secrets case against green iron company Element Zero.

J&J-owned Janssen Pharmaceutica has sued Juno Pharmaceuticals, alleging the Australian off-patent drug maker is threatening to infringe its patent for a schizophrenia drug by seeking to list its own products on the PBS.

Andrew ‘Twiggy’ Forrest’s Fortescue can't get access to nine million seized documents in its trade secrets spat against green iron start-up Element Zero.

IP boutique Davies Collison Cave has brought proceedings against its Melbourne landlord at the Orica House, seeking a declaration that it has not abandoned its lease.